ATE356209T1 - Mutanten des thyroid-stimulierenden hormons - Google Patents

Mutanten des thyroid-stimulierenden hormons

Info

Publication number
ATE356209T1
ATE356209T1 AT98948422T AT98948422T ATE356209T1 AT E356209 T1 ATE356209 T1 AT E356209T1 AT 98948422 T AT98948422 T AT 98948422T AT 98948422 T AT98948422 T AT 98948422T AT E356209 T1 ATE356209 T1 AT E356209T1
Authority
AT
Austria
Prior art keywords
tsh
mutant
thyroid
methods
subunits
Prior art date
Application number
AT98948422T
Other languages
English (en)
Inventor
Bruce D Weintraub
Mariusz W Szkudlinski
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE356209T1 publication Critical patent/ATE356209T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98948422T 1997-09-22 1998-09-22 Mutanten des thyroid-stimulierenden hormons ATE356209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93947297A 1997-09-22 1997-09-22

Publications (1)

Publication Number Publication Date
ATE356209T1 true ATE356209T1 (de) 2007-03-15

Family

ID=25473237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98948422T ATE356209T1 (de) 1997-09-22 1998-09-22 Mutanten des thyroid-stimulierenden hormons

Country Status (10)

Country Link
US (1) US20040266665A1 (de)
EP (2) EP1816199A1 (de)
JP (1) JP2001517445A (de)
KR (4) KR100642592B1 (de)
CN (1) CN1277633A (de)
AT (1) ATE356209T1 (de)
AU (1) AU758156B2 (de)
CA (1) CA2302993A1 (de)
DE (1) DE69837271T2 (de)
WO (1) WO1999015665A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524381A (ja) * 1998-09-22 2003-08-19 ユニヴァーシティ オブ メリーランド，ボルチモア システインノット成長因子ミュータント
KR100423735B1 (ko) * 2000-11-13 2004-03-20 학교법인 포항공과대학교 그레이브스 질환에 길항작용을 하는 펩타이드 및 그의 용도
JP2007513191A (ja) * 2003-12-05 2007-05-24 ザイモジェネティクス，インコーポレイティド 甲状腺刺激ホルモンを用いての炎症の処理方法
AU2005233923A1 (en) * 2004-03-31 2005-10-27 Trophogen, Inc. Human glycoprotein hormone superagonists and uses thereof
DK1971361T3 (da) 2005-12-23 2014-09-08 James D Kelly Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom
MX2009002985A (es) * 2006-09-19 2009-04-01 Genzyme Corp Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).
GB0725201D0 (en) * 2007-12-24 2008-01-30 Asterion Ltd Peptide fusion proteins
GB0808402D0 (en) * 2008-05-09 2008-06-18 Asterion Ltd Tsh
US20110052591A1 (en) * 2009-08-28 2011-03-03 Board Of Regents Of The University Of Texas System Variants of Thyroid Stimulating Hormone Beta
US10358574B2 (en) 2016-07-01 2019-07-23 Hercules Llc Coating compositions containing lactam-functionalized polymer
US20230220026A1 (en) * 2022-01-12 2023-07-13 National Yang Ming Chiao Tung University Nucleic acid carrier for producing the single-chain vegf fusion protein with high physiological stability and dimeric efficiency, preparation method thereof, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE148171T1 (de) * 1989-02-21 1997-02-15 Univ Washington Modifizierte formen von fortpflanzungshormonen
ATE257843T1 (de) * 1994-08-12 2004-01-15 Univ Washington Einzelkettenformen des clycoprotein-hormon- quartetts
US6361992B1 (en) * 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists

Also Published As

Publication number Publication date
AU9499898A (en) 1999-04-12
KR100642586B1 (ko) 2006-11-10
KR100642599B1 (ko) 2006-11-10
CN1277633A (zh) 2000-12-20
US20040266665A1 (en) 2004-12-30
WO1999015665A3 (en) 1999-05-20
KR20050085968A (ko) 2005-08-29
CA2302993A1 (en) 1999-04-01
WO1999015665A2 (en) 1999-04-01
KR100642602B1 (ko) 2006-11-10
KR20050085969A (ko) 2005-08-29
JP2001517445A (ja) 2001-10-09
DE69837271T2 (de) 2007-11-22
EP1017817B1 (de) 2007-03-07
KR100642592B1 (ko) 2006-11-13
EP1017817A2 (de) 2000-07-12
DE69837271D1 (de) 2007-04-19
AU758156B2 (en) 2003-03-13
KR20010030661A (ko) 2001-04-16
EP1816199A1 (de) 2007-08-08
KR20050085970A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
DK524187D0 (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
NO924985D0 (no) Thyroaktiv blanding med vedvarende frigjoering
EP0637239A4 (de) Verfahren zur förderung der stickstoffzurückhaltung beim menschen.
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
DE69837271D1 (de) Mutanten des thyroid-stimulierenden hormons
NO922953L (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
BR9809571A (pt) Composição medicinal e processo para produzì-la
EP0482089A4 (en) Methods of treating or preventing autoimmune uveoretinitis in mammals
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
Ruegamer et al. The effects of p-chlorophenoxyisobutyrate on the turnover rate and distribution of thyroid hormone in the rat
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
Watanabe et al. ‘Flagellate’erythema in dermatomyositis
EP0988316A4 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
BR0010947A (pt) Composição de somatotropina com seringabilidade aperfeiçoada
DE69231098D1 (de) Lyophilisierte zusammensetzung, die s(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion)enthält
FR2648814B1 (fr) L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
庄一义 et al. APOLIPOPROTEIN (a) PHENOTYPES IN CARDIOCEREBROVASCULAR DISEASES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties